Published date: 12 August 2020

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 28 August 2020, 12pm

Contract summary

Industry

  • Supply services of nursing personnel - 79624000

Location of contract

Any region

Value of contract

£1,000,000

Procurement reference

tender_247786/879403

Published date

12 August 2020

Closing date

28 August 2020

Closing time

12pm

Contract start date

1 October 2020

Contract end date

30 September 2021

Contract type

Service contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The COVID-19 human genome sequencing programme will recruit 20,000 people currently or previously in an intensive care unit with coronavirus, as well as 15,000 individuals who have mild or no symptoms during infection. The study aims to understand the genetic factors that influence risk of severe COVID-19. It has been designated as an urgent public health study by the NIHR and is jointly funded by the Department of Health and Social Care, UKRI and NIHR.

Genomics England Limited (GEL) is required to collect 15,000 genomic samples from volunteers who have suffered mild or asymptomatic COVID symptoms to provide a control cohort in support of COVID genomic research. GEL does not have integral sample collection capability, and support from NIHR research nurses and NHS Trusts to collect samples is not guaranteed, nor are they able to support home visits, the preferred collection method. This Contract Notice is to select a provider for the remaining 10,000+ samples to work with GEL from around October 2020 onwards.

Severe Retrospective Cases. Current severe retrospective recruitment numbers indicate that up to 70% of volunteers will request a home visit for their sample collection. As a result, the samples that the collection provider will be required to collect will include both mild, and severe retrospective. The numbers of severe cases will be over and above the 10,000 mild samples but are not currently determined.

Additional Co-recruitment - (not yet confirmed). There is the possibility that the collection provider will also be asked to perform additional sample collection in certain instances. This would result in a 6-8 week period during which the majority, if not all, cases up to a volume of approximately 10,000 would require blood collection that includes the standard collection for the mild samples and other collection services during the same appointment.

More information

Links

About the buyer

Contact name

Paul Nicholson

Address

Dawson Hall, Charterhouse Square
London
EC1M 6BQ
England

Email

paul.nicholson@genomicsengland.co.uk

Website

www.genomicsengland.co.uk